ArticleIn vivo (Athens, Greece)
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.
- Low-Grade Fibromyxoid Sarcoma of the Distal Upper Extremity: A Systematic Review.Hand (New York, N.Y.) · 2024Pooled it
- Recurrent Intra-abdominal Low-Grade Fibromyxoid Sarcoma Managed With Multivisceral Resections: A Case Report.Cureus · 2026Article
- Low-Grade Fibromyxoid Sarcoma and Related Subtypes: A Systematic Review and Pooled Analysis of 773 Cases.Cancers · 2026Review
- A mobile intra-abdominal low-grade fibromyxoid sarcoma arising from the jejunal mesentery in an adolescent: a case report and literature review.Frontiers in pediatrics · 2026Article
- Low-grade fibromyxoid sarcoma of the scrotum: a rare case report.Oxford medical case reports · 2025Article
- Low-grade fibromyxoid sarcoma of the liver in a pediatric patient: Case report.Radiology case reports · 2025Article
- Genomic profiling and pathological assessment of malignant peripheral nerve sheath tumors.Journal of cancer research and clinical oncology · 2025Article
- A rare case of low-grade fibromyxoid sarcoma of the thigh: Diagnostic and therapeutic challenges in a resource-limited setting.International journal of surgery case reports · 2025Article
- An elderly patient with low-grade fibromyxoid sarcoma with early postoperative recurrences and metastases: a case report.Journal of medical case reports · 2025Article
- International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease.The American journal of surgical pathology · 2025Article
- Abdominal Fibromyxoid Sarcoma in Pregnancy: An Unusual Cause of Preterm Labor and Sepsis.AJP reports · 2024Article
- Low-grade fibromyxoid sarcoma in laryngopharynx: the first case report in the literature.Journal of surgical case reports · 2024Article
- Familial multiple endocrine neoplasia type 1 with intrathoracic low-grade fibromyxoid sarcoma.Surgical case reports · 2024Article
- An elderly low-grade fibromyxoid sarcoma patient with early postoperative recurrences and metastases: a case report and literature review.Frontiers in medicine · 2024Article
- Penoscrotal Low-grade fibromyxoid sarcoma, A case report.Urology case reports · 2023Article
- A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy.Calcified tissue international · 2023Article
- Superficial low-grade fibromyxoid sarcoma.Journal of cutaneous pathology · 2023Article
- Comprehensive next-generation sequencing reveals low-grade fibromyxoid sarcoma of the vulva missed by morphological diagnosis: a case report.Frontiers in medicine · 2023Article
- Giant primary low-grade fibromyxoid sarcoma arising from the left pulmonary parenchyma: A case report and literature review.Cancer reports (Hoboken, N.J.) · 2022Review
- PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma.Genes · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLow-grade fibromyxoid sarcoma (LGFMS) is a rare sarcoma subtype with a generally indolent pattern of clinical behaviour, but treatments for advanced disease are limited. PATIENTS AND
methodsA retrospective search of a prospectively maintained institutional database identified 102 patients treated from December 1994 to August 2018. We evaluated the outcome of patients and the efficacy and safety of non-surgical therapies in LGFMS.
resultsNinety-four out of 102 (92.2%) underwent primary resection, seven (6.9%) were treated with systemic therapy and one (1.0%) is currently being treated with pre-operative radiotherapy. The RECIST 1.1 response rate to first-line chemotherapy was 0%, and median progression-free survival was 1.84 months (95% confidence intervaI=0.10-3.6 months).
conclusionConventional systemic therapy has limited efficacy in advanced LGFMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.